Vaccines
-
HPV vaccine slashes cervical cancer rates by 87% among women in the UKThe HPV vaccine reduced cases of cervical cancer by 87% among women in the U.K. who received the vaccine when they were 12 or 13 years old, according to a new study.
By Yasemin Saplakoglu Published
cancer -
Should you mix and match COVID-19 vaccines?Many people will now be able to "mix and match" COVID-19 booster shots — that is, get a different COVID-19 vaccine for a booster, the FDA announced Wednesday (Oct. 20).
By Yasemin Saplakoglu Published
coronavirus -
Which COVID-19 vaccine has the lowest rate of breakthrough infections?Hints in the data suggest the Johnson & Johnson vaccine has the most breakthroughs, while Moderna has the least.
By Nicoletta Lanese Published
coronavirus -
Pfizer and Moderna vaccines may provide years of protection from COVID-19The mRNA vaccines will likely provide protection against the coronavirus for years if it doesn't evolve significantly, a small new study suggests.
By Yasemin Saplakoglu Published
coronavirus -
Novavax's COVID-19 shots are 90% effective, company reportsThe shots are 100% effective against moderate and severe infections.
By Nicoletta Lanese Published
coronavirus -
Should 12-year-olds get the COVID-19 vaccine?The benefits of vaccinating young people against COVID-19 outweigh the risks, experts say.
By Ashley P. Taylor Published
coronavirus -
Is the COVID-19 vaccine causing rare myocarditis cases?Researchers in Israel say they've found a possible link between the Pfizer-BioNTech COVID-19 vaccine and cases of heart inflammation called myocarditis in young men.
By Rachael Rettner Published
coronavirus -
Highly effective malaria vaccine could be a game-changer, early trial suggestsA new malaria vaccine showed to be 77% effective in early clinical trials, the first to pass the World Health Organization's efficacy goal.
By Yasemin Saplakoglu Published
viruses-infections-disease -
Vaccines neutralize New York coronavirus variant in lab dishesThe studies analyzed antibodies drawn from vaccinated people.
By Nicoletta Lanese Published
coronavirus
